Dr. Marijo Bilusic joins Sylvester Comprehensive Cancer Center as Genitourinary Site Leader

Reading Time: 2 minutes

Marijo Bilusic, M.D., Ph.D. has joined Sylvester Comprehensive Cancer Center as Leader of the Genitourinary Cancers Site Disease Group and will hold clinic sessions in Miami.

Marijo Bilusic, M.D., Ph.D.

Dr. Bilusic is a board-certified medical oncologist who treats genitourinary tumors (adrenal, kidney, prostate, bladder, and testis). His current research interests focus on tumor immunology and development of novel immunotherapy approaches for GU and other tumors using therapeutic cancer vaccines, antibodies, or immune modulators.

Dr. Bilusic received his M.D. degree from the University of Zagreb School of Medicine in Croatia and completed his Ph.D. training at the University of Split School of Medicine in Croatia. In addition, he completed a postdoctoral research fellowship in physiological genomics at the Medical College of Wisconsin's Human and Molecular Genetics Center in Milwaukee, Wis. He then completed a clinical fellowship in medical oncology and hematology at the National Cancer Institute and the National Heart, Lung, and Blood Institute in Bethesda, Md.

Dr. Bilusic served as an assistant professor of genitourinary medical oncology at the Fox Chase Cancer Center/Temple Health from 2012-16 and then joined the NCI Medical Oncology Service/Genitourinary Malignancy Branch in 2016 as an Associate Research Physician (equivalent to associate professor). During his time at the NCI, he also served as Associate Program Director, NIH Hematology Oncology Fellowship Program, from July 2016-July 2018, and then as Program Director from July 2018-July 2021.

In 2017 Dr. Bilusic received the NIH Director's Award as a member of NIH Hematology Oncology Fellowship Team for extraordinary resourcefulness and initiative. His passion for teaching and mentoring has earned multiple awards at NIH and NCI. He is board certified in medical oncology, hematology and internal medicine.

    [recaptcha]